OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
LAV.BB57

Lavena AD

Personal ProductsVerified

Lavena AD maintains a strong liquidity position with a current ratio of 5.0, indicating that it has five times more current assets than current liabilities. The company's cash and equivalents amount to BGN 914,000, while its long-term debt is relatively low at BGN 2,001,000, resulting in a debt-to-equity ratio of 0.07. This suggests a conservative capital structure with minimal leverage. In terms of profitability, Lavena AD reports a return on equity (ROE) of 7.38% and a return on assets (ROA) of 6.37%. These figures are in line with the industry's preferred metrics, which emphasize stable returns and efficient asset utilization. The company's operating income of BGN 2,296,000 and net income of BGN 2,191,000 reflect a healthy margin, although the gross profit margin of 41.7% (BGN 10,852,000 on BGN 26,034,000 revenue) suggests room for improvement in cost control. Lavena AD's revenue is concentrated in Bulgaria, with no disclosed international operations. The company's product portfolio is segmented into six main areas: Essential Oils, Hair Care, Children's Care, Face and Body Care, Oral Care, and Aromatherapy. The Children's Care segment, under the Bochko bebe and Bochko kids brands, appears to be a key revenue driver, as it includes a range of products such as diaper rash creams and wet wipes. The company's growth trajectory is modest, with no specific revenue growth projections provided in the latest financial data. However, the introduction of new products such as hand creams and antibacterial hand gels suggests a strategy to expand its product offerings and potentially increase market share. The capital expenditure of BGN -787,000 indicates a reduction in investment, which may be a response to current market conditions or a strategic shift in resource allocation. Risk factors for Lavena AD include a medium liquidity risk, as the company's net cash is negative after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. The company's conservative debt levels and strong equity position mitigate credit risk, although the absence of detailed credit ratings or covenants limits the ability to fully assess long-term financial stability. Recent events and filings for Lavena AD are limited in the provided data. The company's major shareholder, Baltimor EOOD Sofia, holds a 66.61% stake, which may influence strategic decisions and capital allocation. No recent earnings calls or transcripts are available to provide additional insight into management's outlook or operational performance.

30-day price · LAV.BB+0.04 (+4.0%)
Low$1.00High$1.15Close$1.04As of18 May, 00:00 UTC
Profile
CompanyLavena AD
TickerLAV.BB
SectorConsumer Non-Cyclicals
BusinessPersonal & Household Products & Services
Industry groupPersonal & Household Products & Services
IndustryPersonal Products
AI analysis

Business. Lavena AD is a Bulgaria-based company engaged in the personal products industry, specializing in the production and distribution of essential cosmetics, including essential oils, hair care, children's care, face and body care, oral care, and aromatherapy products.

Classification. Lavena AD is classified under the Consumer Non-Cyclicals economic sector, Personal & Household Products & Services business sector, and Personal Products industry, with a classification confidence of 0.92.

Lavena AD maintains a strong liquidity position with a current ratio of 5.0, indicating that it has five times more current assets than current liabilities. The company's cash and equivalents amount to BGN 914,000, while its long-term debt is relatively low at BGN 2,001,000, resulting in a debt-to-equity ratio of 0.07. This suggests a conservative capital structure with minimal leverage. In terms of profitability, Lavena AD reports a return on equity (ROE) of 7.38% and a return on assets (ROA) of 6.37%. These figures are in line with the industry's preferred metrics, which emphasize stable returns and efficient asset utilization. The company's operating income of BGN 2,296,000 and net income of BGN 2,191,000 reflect a healthy margin, although the gross profit margin of 41.7% (BGN 10,852,000 on BGN 26,034,000 revenue) suggests room for improvement in cost control. Lavena AD's revenue is concentrated in Bulgaria, with no disclosed international operations. The company's product portfolio is segmented into six main areas: Essential Oils, Hair Care, Children's Care, Face and Body Care, Oral Care, and Aromatherapy. The Children's Care segment, under the Bochko bebe and Bochko kids brands, appears to be a key revenue driver, as it includes a range of products such as diaper rash creams and wet wipes. The company's growth trajectory is modest, with no specific revenue growth projections provided in the latest financial data. However, the introduction of new products such as hand creams and antibacterial hand gels suggests a strategy to expand its product offerings and potentially increase market share. The capital expenditure of BGN -787,000 indicates a reduction in investment, which may be a response to current market conditions or a strategic shift in resource allocation. Risk factors for Lavena AD include a medium liquidity risk, as the company's net cash is negative after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. The company's conservative debt levels and strong equity position mitigate credit risk, although the absence of detailed credit ratings or covenants limits the ability to fully assess long-term financial stability. Recent events and filings for Lavena AD are limited in the provided data. The company's major shareholder, Baltimor EOOD Sofia, holds a 66.61% stake, which may influence strategic decisions and capital allocation. No recent earnings calls or transcripts are available to provide additional insight into management's outlook or operational performance.
Key takeaways
  • Lavena AD maintains a conservative capital structure with a low debt-to-equity ratio of 0.07 and a strong current ratio of 5.0.
  • The company's profitability is stable, with a return on equity of 7.38% and a return on assets of 6.37%.
  • Revenue is concentrated in Bulgaria, with no disclosed international operations, and the Children's Care segment appears to be a key revenue driver.
  • The company's growth strategy includes the introduction of new products such as hand creams and antibacterial hand gels.
  • Liquidity risk is assessed as medium, and dilution risk is low, with no significant dilution potential identified.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyBGN
Revenue$26.0M
Gross profit$10.9M
Operating income$2.3M
Net income$2.2M
R&D
SG&A
D&A
SBC
Operating cash flow$2.7M
CapEx-$787.0k
Free cash flow$2.2M
Total assets$34.4M
Total liabilities$4.7M
Total equity$29.7M
Cash & equivalents$914.0k
Long-term debt$2.0M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$29.7M
Net cash-$1.1M
Current ratio5.0
Debt/Equity0.1
ROA6.4%
ROE7.4%
Cash conversion1.2%
CapEx/Revenue-3.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Personal Products · cohort 225 companies
MetricLAV.BBActivity
Op margin8.8%16.2% medp25 16.2% · p75 16.2%bottom quartile
Net margin8.4%10.5% medp25 10.5% · p75 10.5%bottom quartile
Gross margin41.7%60.1% medp25 60.1% · p75 60.1%bottom quartile
R&D / revenue1.8% medp25 1.8% · p75 1.8%
CapEx / revenue-3.0%-2.3% medp25 -4.4% · p75 -1.1%below median
Debt / equity7.0%12724.1% medp25 12724.1% · p75 12724.1%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 23:53 UTC#56e5ab7d
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 23:54 UTCJob: e5b09e16